OBJECTIVE: Mutations in the gene encoding the prion protein (PrP) are responsible for approximately 10 to 15% of cases of prion disease in humans, including Creutzfeldt-Jakob disease (CJD). Here, we report on the discovery of a previously unreported C-terminal PrP mutation (A224V) in a CJD patient exhibiting a disease similar to the rare VV1 subtype of sporadic (s) CJD and investigate the role of this mutation in prion replication and transmission. METHODS: We generated transgenic (Tg) mice expressing human PrP with the V129 polymorphism and A224V mutation, denoted Tg(HuPrP,V129,A224V) mice, and inoculated them with different subtypes of sCJD prions. RESULTS: Transmission of sCJD VV2 or MV2 prions was accelerated in Tg(HuPrP,V129,A224V) mice, compared to Tg(HuPrP,V129) mice, with incubation periods of ∼110 and ∼210 days, respectively. In contrast, sCJD MM1 prions resulted in longer incubation periods in Tg(HuPrP,V129,A224V) mice, compared to Tg(HuPrP,V129) mice (∼320 vs. ∼210 days). Prion strain fidelity was maintained in Tg(HuPrP,V129,A224V) mice inoculated with sCJD VV2 or MM1 prions, despite the altered replication kinetics. INTERPRETATION: Our results suggest that A224V is a risk factor for prion disease and modulates the transmission behavior of CJD prions in a strain-specific manner, arguing that residues near the C-terminus of PrP are important for controlling the kinetics of prion replication.
OBJECTIVE: Mutations in the gene encoding the prion protein (PrP) are responsible for approximately 10 to 15% of cases of prion disease in humans, including Creutzfeldt-Jakob disease (CJD). Here, we report on the discovery of a previously unreported C-terminal PrP mutation (A224V) in a CJDpatient exhibiting a disease similar to the rare VV1 subtype of sporadic (s) CJD and investigate the role of this mutation in prion replication and transmission. METHODS: We generated transgenic (Tg) mice expressing humanPrP with the V129 polymorphism and A224V mutation, denoted Tg(HuPrP,V129,A224V) mice, and inoculated them with different subtypes of sCJD prions. RESULTS: Transmission of sCJD VV2 or MV2 prions was accelerated in Tg(HuPrP,V129,A224V) mice, compared to Tg(HuPrP,V129) mice, with incubation periods of ∼110 and ∼210 days, respectively. In contrast, sCJD MM1 prions resulted in longer incubation periods in Tg(HuPrP,V129,A224V) mice, compared to Tg(HuPrP,V129) mice (∼320 vs. ∼210 days). Prion strain fidelity was maintained in Tg(HuPrP,V129,A224V) mice inoculated with sCJD VV2 or MM1 prions, despite the altered replication kinetics. INTERPRETATION: Our results suggest that A224V is a risk factor for prion disease and modulates the transmission behavior of CJD prions in a strain-specific manner, arguing that residues near the C-terminus of PrP are important for controlling the kinetics of prion replication.
Authors: Karah E Nazor; Franziska Kuhn; Tanya Seward; Mike Green; Daniel Zwald; Mario Pürro; Jaqueline Schmid; Karin Biffiger; Aisling M Power; Bruno Oesch; Alex J Raeber; Glenn C Telling Journal: EMBO J Date: 2005-06-16 Impact factor: 11.598
Authors: S J Collins; P Sanchez-Juan; C L Masters; G M Klug; C van Duijn; A Poleggi; M Pocchiari; S Almonti; N Cuadrado-Corrales; J de Pedro-Cuesta; H Budka; E Gelpi; M Glatzel; M Tolnay; E Hewer; I Zerr; U Heinemann; H A Kretszchmar; G H Jansen; E Olsen; E Mitrova; A Alpérovitch; J-P Brandel; J Mackenzie; K Murray; R G Will Journal: Brain Date: 2006-07-01 Impact factor: 13.501
Authors: Geoffrey S Young; Michael D Geschwind; Nancy J Fischbein; Jennifer L Martindale; Roland G Henry; Songling Liu; Ying Lu; Stephen Wong; Hong Liu; Bruce L Miller; William P Dillon Journal: AJNR Am J Neuroradiol Date: 2005 Jun-Jul Impact factor: 3.825
Authors: B Meissner; I M Westner; K Kallenberg; A Krasnianski; M Bartl; D Varges; C Bösenberg; H A Kretzschmar; M Knauth; W J Schulz-Schaeffer; I Zerr Journal: Neurology Date: 2005-10-12 Impact factor: 9.910
Authors: G C Telling; P Parchi; S J DeArmond; P Cortelli; P Montagna; R Gabizon; J Mastrianni; E Lugaresi; P Gambetti; S B Prusiner Journal: Science Date: 1996-12-20 Impact factor: 47.728
Authors: Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge Journal: J Gen Virol Date: 2009-03 Impact factor: 3.891
Authors: Anna Krasnianski; Mario Bartl; Pascual J Sanchez Juan; Uta Heinemann; Bettina Meissner; Daniela Varges; Ulf Schulze-Sturm; Haus A Kretzschmar; Walter J Schulz-Schaeffer; Inga Zerr Journal: Ann Neurol Date: 2008-05 Impact factor: 10.422
Authors: Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind Journal: Cold Spring Harb Perspect Biol Date: 2018-05-01 Impact factor: 10.005
Authors: Joel C Watts; Kurt Giles; Matthew E C Bourkas; Smita Patel; Abby Oehler; Marta Gavidia; Sumita Bhardwaj; Joanne Lee; Stanley B Prusiner Journal: Acta Neuropathol Date: 2016-06-28 Impact factor: 17.088
Authors: Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2017-01 Impact factor: 3.568
Authors: Ignazio Cali; Juan Carlos Espinosa; Satish K Nemani; Alba Marin-Moreno; Manuel V Camacho; Rabail Aslam; Tetsuyuki Kitamoto; Brian S Appleby; Juan Maria Torres; Pierluigi Gambetti Journal: Acta Neuropathol Commun Date: 2021-03-25 Impact factor: 7.801
Authors: Emmanuel A Asante; Jacqueline M Linehan; Andrew Tomlinson; Tatiana Jakubcova; Shyma Hamdan; Andrew Grimshaw; Michelle Smidak; Asif Jeelani; Akin Nihat; Simon Mead; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge Journal: PLoS Biol Date: 2020-06-09 Impact factor: 8.029